Bloomage Biotech

Bloomage Biotech is a Chinese biotech and bioactive materials company best known as the world's largest producer and seller of hyaluronic acid, with a 38.96% global market share in 2019 according to Frost & Sullivan — larger than the next four competitors combined . Founded in 2001 when Huaxi International Investment Group acquired its predecessor Shandong Freda Biochemical Engineering and its microbial fermentation technology, the company built its moat on bio-fermentation capabilities that it extended into cross-linking technology platforms and downstream injectable and filler products .

The company has been described as "the Huawei of the medical aesthetics industry" for its vertically integrated control over core technology, from fermentation platforms to finished products . Beyond its dominant hyaluronic acid business, Bloomage has pursued horizontal expansion through acquisitions including French firm Revitacare and Dongying Fost Biotech, while also pushing into C-facing categories like functional foods — it secured approval in January 2021 to add sodium hyaluronate to ordinary foods and launched the "Hei Ling" brand . More recently, it has begun deploying its capital as a strategic investor, participating as industrial capital in AI2Robotics' funding rounds to enter biotech manufacturing scenarios .